literature when available and based on assumptions otherwise. The error occurred in the calculation of bias for syndromes tuberous sclerosis complex (TSC) and von Hippel-Lindau (VHL) and brain tumor risk. More specifically, the error occurred in the calculation of the relative risk of brain tumors among patients with TSC or VHL disease compared with the general population (RR_ CD in the formula). Because of the error, the estimates for these two relative risks were too high, 2,500 and 28,000, respectively, when they should have been 125 and 142. Because of the large (and incorrect) relative risks used, bias of TSC and VHL disease was substantial for several scenarios. As a result, the authors concluded that TSC is a potentially important confounder for brain tumor risks in CT studies. The authors originally concluded that, "associations with leukemia reported in previous studies are unlikely to be substantially confounded by unmeasured CSS, whereas brain tumor risks might have been overestimated due to confounding by TSC" (1) . In light of the analytical error, the reassessment indicates that associations with leukemia and brain tumors reported in previous studies are unlikely to be substantially confounded by unmeasured CSS.
